FLURBIPROFEN AXETIL: 85 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
85
Total FAERS Reports
9 (10.6%)
Deaths Reported
35
Hospitalizations
85
As Primary/Secondary Suspect
19
Life-Threatening
10
Disabilities
First Report: 20090610 · Latest Report: 20250327
What Are the Most Common FLURBIPROFEN AXETIL Side Effects?
#1 Most Reported
Hepatic function abnormal
20 reports (23.5%)
#2 Most Reported
Diarrhoea
8 reports (9.4%)
#3 Most Reported
Thrombotic microangiopathy
5 reports (5.9%)
All FLURBIPROFEN AXETIL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hepatic function abnormal | 20 | 23.5% | 1 | 11 |
| Diarrhoea | 8 | 9.4% | 0 | 7 |
| Acute kidney injury | 5 | 5.9% | 0 | 3 |
| Adenovirus infection | 5 | 5.9% | 0 | 5 |
| Anaphylactic shock | 5 | 5.9% | 0 | 2 |
| Graft versus host disease | 5 | 5.9% | 0 | 5 |
| Hyperglycaemia | 5 | 5.9% | 0 | 5 |
| Ileus paralytic | 5 | 5.9% | 0 | 5 |
| Pneumothorax | 5 | 5.9% | 0 | 5 |
| Pyrexia | 5 | 5.9% | 1 | 4 |
| Respiratory disorder | 5 | 5.9% | 0 | 5 |
| Thrombotic microangiopathy | 5 | 5.9% | 0 | 5 |
Who Reports FLURBIPROFEN AXETIL Side Effects? Age & Gender Data
Gender: 64.7% female, 35.3% male. Average age: 46.2 years. Most reports from: JP. View detailed demographics →
Is FLURBIPROFEN AXETIL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 7 | 1 | 5 |
| 2014 | 2 | 0 | 2 |
| 2015 | 7 | 0 | 5 |
| 2016 | 7 | 3 | 2 |
| 2017 | 8 | 3 | 4 |
| 2018 | 2 | 0 | 1 |
| 2019 | 7 | 0 | 1 |
| 2020 | 6 | 0 | 2 |
| 2021 | 12 | 1 | 4 |
| 2022 | 7 | 1 | 0 |
| 2023 | 3 | 0 | 2 |
| 2024 | 6 | 0 | 1 |
| 2025 | 3 | 0 | 2 |
What Is FLURBIPROFEN AXETIL Used For?
| Indication | Reports |
|---|---|
| Analgesic therapy | 29 |
| Product used for unknown indication | 9 |
Official FDA Label for FLURBIPROFEN AXETIL
Official prescribing information from the FDA-approved drug label.